approval
saveABRILADA (ADALIMUMAB-AFZB) — FDA approval
community read0 votes
Sponsor: PFIZER INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalABRILADA (ADALIMUMAB-AFZB) — FDA approvalApr 30, 2024 · 887d ago
- approvalABRILADA (ADALIMUMAB-AFZB) — FDA approvalOct 4, 2023 · 1096d ago
- approvalABRILADA (ADALIMUMAB-AFZB) — FDA approvalAug 16, 2023 · 1145d ago
- approvalABRILADA (ADALIMUMAB-AFZB) — FDA approvalJun 14, 2023 · 1208d ago
- approvalABRILADA (ADALIMUMAB-AFZB) — FDA approvalJul 29, 2022 · 1528d ago
- approvalABRILADA (ADALIMUMAB-AFZB) — FDA approvalNov 15, 2019 · 2515d ago
same company · ±60 days · 6
- approvalmarstacimab: HYMPAVZI (MARSTACIMAB-HNCQ) — FDA approvalDec 16, 2025
- approvalmedroxyprogesterone acetate: DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 12, 2025
- approvalalprostadil: PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approvalDec 22, 2025
- approvaltaliglucerase alfa: ELELYSO (TALIGLUCERASE ALFA) — FDA approvalDec 22, 2025
- approvalmedroxyprogesterone acetate: DEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 12, 2025
- approvalnafarelin acetate: SYNAREL (NAFARELIN ACETATE) — FDA approvalNov 24, 2025
🐶 often sniffed alongside
top 8- tagApproval190 co-mentions · 88 sources
- drugHUMIRA176 co-mentions · 88 sources
- drugadalimumab156 co-mentions · 88 sources
- drugAMJEVITA81 co-mentions · 81 sources
- drugYUSIMRY81 co-mentions · 81 sources
- company$ABBVAbbVie Inc.61 co-mentions · 61 sources
- drugCYLTEZO24 co-mentions · 12 sources
- drugIDACIO16 co-mentions · 8 sources
comments(0)
5-min edit window · permanent after that